Author Question: On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ ... (Read 34 times)

scienceeasy

  • Hero Member
  • *****
  • Posts: 565
On which of the following pharmacological dimensions does cannabis (delta-9-THC) differ significantly from LSD, psilocybin and mescaline?
 
  a. the degree to which they induce profound and intense perceptual distortions and hallucinatory experiences
  b. their effects on wakefulness
  c. the rate at which tolerance develops to their subjective effects
  d. all of these

Question 2

The major psychoactive compound in marijuana, delta-9-THC, has actions mediated by CB1 receptors. An endogenous ligand for this class of receptors is called
 
  a. dopamine
  b. serotonin
  c. acetylcholine
  d. anandamide



xiaomengxian

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

d

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

For a complete list of videos, visit our video library